Chr. Hansen Holding A/S (CRTSF)
Chr. Hansen Holding A/S operates in the Chemicals - Specialty industry of the Basic Materials sector, headquartered in Horsholm, DK. The stock last traded at $79.30, up 5.73% on the session, giving a market capitalisation of $10.44B. On trailing twelve-month figures it carries a trailing P/E of 42.74, a net margin of 17.0%. Its beta of 0.33 implies it has historically moved less than the broad market.
Chr. Hansen Holding A/S is a global bioscience firm dedicated to developing natural ingredient solutions. These innovative offerings serve the food, nutritional, pharmaceutical, and agricultural sectors across a wide geographical spread, encompassing Europe, the Middle East, Africa, North America, Latin America, and the Asia Pacific region. The company's operations are divided into two main segments: Food Cultures & Enzymes, and Health & Nutrition. Within the Food Cultures & Enzymes division, Chr. Hansen manufactures and supplies a diverse range of cultures, enzymes, and probiotic products. These essential components are pivotal in shaping the taste, aroma, texture, preservation, nutritional profile, and health advantages of various consumer food items, particularly within the dairy industry. The Health & Nutrition segment, on the other hand, provides specialized products for markets such as dietary supplements, over-the-counter pharmaceuticals, infant nutrition, animal feed, and crop protection. Furthermore, Chr. Hansen has established a strategic partnership with UPL Ltd. to jointly advance and commercialize microbial biological solutions aimed at fostering sustainable agriculture. This enterprise, founded in 1843, is based in Hørsholm, Denmark.
Chr. Hansen Holding A/S is most often compared with the following Basic Materials names: